|
|
|
| You are here: Investors / Corporate Governance |
Supervisory board and the board of directors announced at the December 15th, 2010 the following compliance declaration. Statement of compliance by CyBio AG regarding the German Corporate Governance Code pursuant § 161 of the Stock Corporation Act CyBio AG has conformed with the recommendations of the government commission on the 'German Corporate Governance Code' for the management and surveillance of companies quoted on the stock exchange, in the version dated June 18, 2009 since the submission of the last declaration of conformity on December 17, 2009 together with divergences mentioned in that report, and also intends to comply with the recommendations of the government commission on the 'German Corporate Governance Code' in the version dated May 26, 2010 in the future with the following exceptions: | Section 3.8 | According to the recommendations of the German Corporate Governance Code, the Company should arrange an appropriate deductible for members of the Supervisory Board when contracting D&O insurance (directors’ and officers’ insurance protection). D&O insurance has already been contracted for the Supervisory Board members without a deductible. In view of the infrastructure for Supervisory Board compensation, it is not considered appropriate to impose such a deductible on the members of the Supervisory Board. | | Section 4.2.3 | According to the recommendations of the German Corporate Governance Code, variable compensation for the members of the Executive Board should essentially have a multi-annual evaluation basis. CyBio AG cannot follow this recommendation as the contracts with the members of the Executive Board have short-term time periods (from two to three years) and such relatively short terms of office do not accord with a multi-annual evaluation basis. According to the recommendations of the German Corporate Governance Code, variable amounts of compensation for members of the Executive Board should take consideration of negative developments. CyBio AG has agreed no variable compensation aspects with the members of the Executive Board, as the Company focuses on the conclusion of contracts with a low fixed compensation, which contradicts a bonus-penalty arrangement. According to the recommendations of the German Corporate Governance Code, the Company is to see, that two amounts of annual compensation should not be exceeded when concluding contracts with members of the Executive Board, where payments made to an Executive Board member upon an early termination of Executive Board activities (on non-material grounds) including side services, are paid out. CyBio AG is unable to comply with this recommendation in each and every case. In view of the essentially short-term time period of office of the members, the Supervisory Board assumes, that it will not be necessary in any of the cases to impose the recommended limit under the present contracts. | | Section 5.1.2 | According to the recommendations of the German Corporate Governance Code, an age limit should be imposed on the Supervisory Board members. CyBio AG deems a compliance with this recommendation unnecessary, as the short-term time periods of the contracts concluded, permit sufficient monitoring of the age limit. | | Section 5.2 and 5.3 | According to the recommendations of the German Corporate Governance Code, the Supervisory Board should form qualified expert committees, independent of the specific situational circumstances of the Company and the number of the board members. The chairman of the Supervisory Board should continue to chair the committees, which handle the contracts with the members of the Executive Board and, which prepare for the meetings of the Supervisory Board. Compensation to the Supervisory Board members should, among other things, take account of such chairmanship and the membership of such committees. The Supervisory Board of CyBio AG comprises the statutory minimum of members, being three persons and therefore can form no committees because of its minimal size. | | Section 5.4.1 | According to the recommendations of the German Corporate Governance Code, the Supervisory Board should set concrete aims for its membership. In this regard, an appropriate number of women should be taken into consideration. As already mentioned, the Supervisory Board comprises only the statutory minimum membership of three persons. Because of the relatively small size of the Company, and the limitation to the statutory minimum of the Supervisory Board, CyBio AG is unable to comply with this recommendation. In other respects, it is intended, that the majority shareholder: Analytik Jena AG can look after its interests via an appropriate representation on the Supervisory Board. Any kind of discrimination against candidates for the Supervisory Board on the grounds of sex, is essentially rejected by the Company. | | Section 5.4.6 | In divergence from the recommendation of the German Corporate Governance Code that the Supervisory Board members should receive remuneration based on success-oriented compensation alongside a fixed amount of compensation, the members of the Supervisory Board of CyBio AG receive only a fixed services’ compensation and a meeting fee. A form of variable compensation is waived in view of the size of the Company.
|
The Executive Board and the Supervisory Board welcome the recommendations of the German Corporate Governance Code, thus furthering the confidence of national and international investors, customers, interested parties and the public at large, in stock exchange-quoted German joint stock companies, by means of transparency. It can however transpire in individual cases that recommendations fail to suit the situational circumstances in the entrepreneurial practice of CyBio AG. Jena, December 15, 2010
Corporate governance signifies an international understanding of a responsible, transparent and long-term, value added-inclined leadership and control of businesses. The efficient co-operation between the management and supervisory board, an orientiation towards the rights and interests of shareholders, directness and clarity in communication are all valuable aspects of Corporate Governance.
Phone: +49.3641.351 495 E-mail: irpr@cybio-ag.com
Here, the important documents to the theme of Corporate Governance are provided:
|
|
|
|
|
|
|